Multiple displacement amplification begins when random primers bind at many positions across the available template. Phi29 DNA polymerase then extends those primers and displaces previously synthesized strands, producing long DNA products while the reaction remains isothermal, meaning it does not rely on repeated temperature cycling. This combination enables broad genome copying from limited starting material for downstream analysis.
Whole Genome Amplification can be performed through more than one amplification strategy. Multiple displacement amplification uses phi29 polymerase under isothermal conditions, whereas other approaches use PCR cycling. That distinction matters when interpreting the resulting material because the selected method determines how DNA synthesis is initiated and carried out, while both approaches serve the broader goal of enabling genomic analysis from scarce samples.
Amplification bias can make some genomic regions more strongly represented than others, so the amplified material may not reflect the starting genome uniformly. Contamination is another concern when very little original DNA is present, because unwanted DNA can influence downstream sequencing or genetic analysis. Careful controls are therefore essential for distinguishing sample-derived findings from technical artifacts.
An analysis workflow starts with a limited clinical, environmental, cellular, or microbial specimen, followed by selection of a WGA strategy and amplification of its available DNA. The resulting material can then be directed to sequencing or other genetic analysis. Because the input is scarce, interpreting results requires attention to the method’s potential bias and to contamination controls.
When a pathogen cannot readily be characterized from abundant material, Whole Genome Amplification can provide DNA for genomic investigation from an uncultured microbe or a limited clinical specimen. The amplified product may support pathogen genome characterization and sequencing, while environmental samples extend the approach beyond clinical settings. Its value is greatest when the original biological material is insufficient for direct analysis.
In immunology and infection research, the method can connect scarce biological material with questions about both the infectious agent and the host. Researchers can use it to examine pathogen genomes, investigate host genetic variation, or study rare infected cells. These applications expand analysis to samples that might otherwise provide too little DNA, but findings still require careful interpretation because amplification can introduce bias.